News und Analysen
Quidel Receives Emergency Use Authorization for Moderately Complex Solana® SARS Molecular Test for COVID-19 Diagnosis
Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has
EOS imaging Announces Its Financial Agenda For 2021
Regulatory News:
EOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI - Eligible PEA - PME), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and
Novocure to Participate in the 39th Annual J.P. Morgan Virtual Healthcare Conference
Novocure (NASDAQ: NVCR) will participate virtually in the 39th Annual J.P. Morgan Healthcare Conference on January 11 through January 14, 2021. William Doyle, Novocure’s Executive Chairman, will
Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a second agreement with the U.S. government to supply an additional 100 million doses of the companies’ COVID-19 Vaccine from
Agilent Receives Approval for GenetiSure Dx Postnatal Assay in Japan
Agilent Technologies Inc. (NYSE: A) announced it has obtained clearance from the Ministry of Health, Labour and Welfare (MHLW) in Japan for the GenetiSure Dx Postnatal Assay – a microarray-based
Pfizer Invites Public to View and Listen to Webcast of February 2 Conference Call with Analysts
Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EST on Tuesday, February 2, 2021. The
Illumina to Webcast Upcoming Investor Conference Presentations
Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference and invited investors to participate via webcast.
J.P. Morgan Virtual
Humana Inc. to Present at the Goldman Sachs 13th Annual Healthcare CEOs Unscripted Conference: A View from the Top
Humana Inc. (NYSE: HUM) announced today that Bruce D. Broussard, President and Chief Executive Officer, will make a presentation to investors at the Goldman Sachs Annual Healthcare CEO Conference
VFMCRP and ChemoCentryx Provide Topline Results From ACCOLADE Trial of Avacopan in C3 Glomerulopathy Including Improved Estimated Glomerular Filtration Rate (eGFR)
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201221005694/en/
Vifor Fresenius Medical Care Renal Pharma (VFMCRP)
Pfizer and BioNTech Receive Authorization in the European Union for COVID-19 Vaccine
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the European Commission (EC) has granted a conditional marketing authorization (CMA) to Pfizer and BioNTech for COMIRNATY
Humana Announces Nearly $1 Million in Financial Relief to Six Oklahoma Community Service Organizations
As Oklahomans face extraordinary challenges during difficult times, leading health and well-being company Humana Inc. (NYSE: HUM) today announced grants totaling nearly $1 million to six nonprofit
Pfizer and BioNTech Receive CHMP Positive Opinion for their COVID-19 Vaccine
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive
Quidel Receives Emergency Use Authorization for QuickVue® SARS Rapid Antigen Test for COVID-19 Diagnosis
Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that Quidel
Clovis Oncology’s Rubraca® (rucaparib) Met the Primary Endpoint of Significantly Improving Progression-Free Survival vs. Chemotherapy in the ARIEL4 Randomized Phase 3 Treatment Study in Later-line Ovarian Cancer Patients with a BRCA mutation
Clovis Oncology, Inc. (NASDAQ: CLVS), today announced topline data from the randomized Phase 3 ARIEL4 study of Rubraca, which met its primary endpoint of improved investigator-assessed
Health Resource Services (HRS) Moves to Premier Inc. for Superior National Contract Portfolio and Comprehensive, Cross-Continuum Spend Management Services
Health Resource Services (HRS), a national, provider-owned group purchasing organization (GPO) founded by Virginia Mason Health System, today announced that they will partner with Premier Inc.
Transgene and BioInvent Receive CTA Approval for Phase 1/2a Trial of Oncolytic Virus BT-001 in Solid Tumors
Regulatory News:
Transgene (Paris:TNG) (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and BioInvent International AB
European Commission Approves Aimmune’s PALFORZIA® as First-Ever Treatment for Peanut Allergy in the EU
Aimmune Therapeutics, Inc., a Nestlé Health Science Company, today announced that the European Commission (EC) has approved PALFORZIA® [defatted powder of Arachis hypogaea L., semen (peanuts)] for
Nanobiotix Announces Closing of Underwriters’ Option to Purchase Additional ADSs
Regulatory News:
NANOBIOTIX (Paris:NANO) (Euronext: NANO – Nasdaq: NBTX – the ‘‘Company’’), a clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today
Lysogene Announces a Change in the Organization of KGA, Minority Shareholder of Lysogene
Regulatory News:
Lysogene (Paris:LYS) (FR0013233475 – LYS), a phase 3 gene therapy platform Company targeting central nervous system (CNS) diseases, announces a change in the governance and
THERANEXUS, LYON NEUROSCIENCE RESEARCH CENTER AND CERMEP ANNOUNCE THE CREATION AND FUNDING OF NEW JOINT PUBLIC/PRIVATE LABORATORY "NEUROIMAGING FOR DRUG DISCOVERY" (NI2D)
The laboratory obtained funding of €350,000 from the French National Research Agency (ANR).
Lyon, 18 December 2020 – Theranexus, a biopharmaceutical company innovating in the treatment of
Aurinia gibt Kooperations- und Lizenzvertrag mit Otsuka Pharmaceutical Co., Ltd. über die Entwicklung und Vermarktung von Voclosporin in Europa und Japan bekannt
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX:AUP) („Aurinia“ oder das „Unternehmen“) gab heute den Abschluss eines Kooperations- und Lizenzvertrags mit Otsuka Pharmaceutical Co., Ltd. über die
QIAGEN unterstreicht innovatives Engagement für Nachhaltigkeit mit einem EUR 400 Mio. syndiziertem Kredit mit Nachhaltigkeitsbezug
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard QIA) gab heute den erfolgreichen Abschluss eines syndizierten revolvierenden Kredits über EUR 400 Mio. bekannt, deren Zinssatz an die Umwelt-
QIAGEN Underlines and Innovates Its Commitment to Sustainability With a EUR 400mn Sustainability-linked Credit Facility
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard QIA) announced today that it has successfully concluded a syndicated revolving credit facility for EUR 400mn with an interest rate linked to the
Transgene Announces Financial Calendar for 2021
Regulatory News
Transgene (Paris:TNG) today announced its financial reporting dates for 2021:
March 10, 2021:
2020 Fiscal Year Results
April 27, 2021:
First
AMN Healthcare Named as One of America’s Most Responsible Companies for 2021
For its dedication to addressing social issues and supporting people and communities locally, nationally and globally, AMN Healthcare (NYSE: AMN) has been named one of the country’s most